18:10 IST
BSE
Board Meeting Date
Mangalam Drugs and Organics Board Meeting Date
Mangalam Drugs & Organics will hold a board meeting on August 12, 2026, to consider unaudited financial results and appoint auditors.
Mangalam Drugs and Organics Ltd
- Share price
- ₹33.09
- Market cap
- ₹52.38 Cr
- Revenue (annual)
- ₹232.1 Cr
- Net profit (annual)
- ₹-44.40 Cr
- P/E (TTM)
- -1.4×Sector 47.3×
- Promoter holding
- 35.65%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Share Pledge 5Other Announcement 5Debt & Borrowing 5Management Change 4Financial Results 3Board Meeting Date 3Annual General Meeting 3Legal & Regulatory 2Adverse Business Impact 2Board Meeting Outcome 1
Time
3 announcements with these filters
10:53 IST
NSE
Board Meeting Date
Mangalam Drugs and Organics Board Meeting Date
Mangalam Drugs and Organics Limited has scheduled a board meeting for May 14, 2026, to consider and approve its audited standalone and consolidated financial results for the year ended March 31, 2026. The company's trading window remains closed until May 16, 2026, in compliance with insider trading regulations.
19:36 IST
BSE
Board Meeting Date
Mangalam Drugs and Organics Board Meeting Date
Mangalam Drugs and Organics Limited has scheduled a board meeting on May 14, 2026, to consider and approve audited financial results for the quarter and year ended March 31, 2026. Consequently, the trading window for dealing in company securities is closed from April 1, 2026, until 48 hours after the results announcement.